Log in
Enquire now
‌

US Patent 12006318 Crystalline forms of C-C chemokine receptor type 4 antagonist and uses thereof

Patent 12006318 was granted and assigned to RAPT Therapeutics on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
RAPT Therapeutics
RAPT Therapeutics
0
Current Assignee
RAPT Therapeutics
RAPT Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120063180
Patent Inventor Names
Sami Karaborni0
David J. Arnold0
Omar Robles0
David J. Wustrow0
Mikhail Zibinsky0
Duane E. Rudisill0
Date of Patent
June 11, 2024
0
Patent Application Number
170981570
Date Filed
November 13, 2020
0
Patent Citations
‌
US Patent 10179787 Chemokine receptor modulators and uses thereof
0
Patent Primary Examiner
‌
John S Kenyon
0
CPC Code
‌
C07D 487/04
0
Patent abstract

Crystalline forms of a C-C chemokine receptor type 4 (CCR4) antagonist, oral dosage forms of same and methods of using and preparing same, are provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 12006318 Crystalline forms of C-C chemokine receptor type 4 antagonist and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.